Literature DB >> 12532311

Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: a review.

N Zisapel1, M Laudon.   

Abstract

The Leeds sleep evaluation questionnaire (LSEQ) comprises ten self-rating 100 mm line analogue questions concerned with sleep and early morning behaviour. A literature search identified 83 studies in peer-reviewed journals that reported the use of the LSEQ for psychopharmacological investigations of drug effects on self-reported aspects of sleep. High internal consistency and reliability of the questionnaire have been demonstrated. Findings from studies involving a variety of psychoactive agents indicated that the LSEQ was able to quantify subjective impressions of sleep and waking and the effects of drugs in healthy volunteers, depressed and insomnia patients. In accordance with their known activity profile nocturnal administration of sedative hypnotic agents and antihistamines induced dose-related improvements in self-reported ease of getting to sleep, and quality of sleep but a decrease in alertness and behavioural integrity the following morning. Psychostimulants, on the other hand, impaired subjective ratings of sleep and increased early morning alertness. Antidepressants and certain anxiolytic agents improved both self-reported sleep aspects and early morning alertness. Treatment effects measured by the LSEQ corresponded to those measured for the same drugs by other assessment methods. These data indicate that the LSEQ is a robust and reliable instrument for psychopharmacological evaluations. Self-evaluations of sleep, as obtained by the LSEQ, can therefore provide consistent and meaningful measures for estimating the effectiveness of sleep modulators and sedative-hypnotic drugs. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12532311     DOI: 10.1002/hup.455

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  13 in total

Review 1.  A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults.

Authors:  Emily Beth Devine; Zafar Hakim; Jesse Green
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.

Authors:  Ian Hindmarch; Eric Legangneux; Neil Stanley; Steve Emegbo; Jean Dawson
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

3.  Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers.

Authors:  Anne C Baakman; Rob Zuiker; Joop M A van Gerven; Nicholas Gross; Ronghua Yang; Michael Fetell; Ari Gershon; Yossi Gilgun-Sherki; Edward Hellriegel; Ofer Spiegelstein
Journal:  Br J Clin Pharmacol       Date:  2019-03-14       Impact factor: 4.335

Review 4.  Antidepressants and sleep: a qualitative review of the literature.

Authors:  Sue Wilson; Spilios Argyropoulos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Authors:  Marcio Versiani; Ricardo Moreno; Catharina J A Ramakers-van Moorsel; Albert J Schutte
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial.

Authors:  Catherine Cornu; Laurent Remontet; Florence Noel-Baron; Alain Nicolas; Nathalie Feugier-Favier; Pascal Roy; Bruno Claustrat; Mitra Saadatian-Elahi; Behrouz Kassaï
Journal:  BMC Complement Altern Med       Date:  2010-06-22       Impact factor: 3.659

7.  Use of Selective Serotonin Reuptake Inhibitors and Sleep Quality: A Population-Based Study.

Authors:  Nikkie Aarts; Lisette A Zuurbier; Raymond Noordam; Albert Hofman; Henning Tiemeier; Bruno H Stricker; Loes E Visser
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

8.  Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.

Authors:  Julia Boyle; Malin E V Eriksson; Laura Gribble; Ravi Gouni; Sigurd Johnsen; David V Coppini; David Kerr
Journal:  Diabetes Care       Date:  2012-09-18       Impact factor: 19.112

9.  Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials.

Authors:  Patrick Lemoine; Alan G Wade; Amnon Katz; Tali Nir; Nava Zisapel
Journal:  Integr Blood Press Control       Date:  2012-01-25

10.  Does caffeine reduce postoperative bowel paralysis after elective laparoscopic colectomy? (CaCo trial): study protocol for a randomized controlled trial.

Authors:  Christina Kruse; Sascha A Müller; René Warschkow; Cornelia Lüthi; Walter Brunner; Lukas Marti; Michael Christian Sulz; Bruno M Schmied; Ignazio Tarantino; Ulrich Beutner
Journal:  Trials       Date:  2016-04-04       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.